4.6 Review

Antithrombotic treatment after stroke due to intracerebral haemorrhage

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study

Peter Bronnum Nielsen et al.

Summary: The study found that patients with ICH and AF have a high risk of cerebrovascular ischemic events and a very high risk of all-cause death one year after the incident. Further clinical trials are needed to determine the optimal stroke prevention treatment for ICH survivors with AF.

STROKE (2022)

Article Clinical Neurology

Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study

C. Qian et al.

Summary: This study found that administering 40 mg/d LMWH for prevention of VTE to spontaneous ICH patients is safe regardless of whether it is started 24 h (early) or 72 h (late) after the hemorrhage. Early LMWH treatment does not increase risk of hemorrhage enlargement, and late administration does not increase the occurrence of VTE.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Clinical Neurology

Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

Floris H. B. M. Schreuder et al.

Summary: The APACHE-AF trial aimed to compare the effects of restarting anticoagulation and permanently avoiding anticoagulation in patients with atrial fibrillation who survived an anticoagulation-associated intracerebral haemorrhage. The study found that patients have a high subsequent annual risk of non-fatal stroke or vascular death, regardless of whether they were allocated to apixaban or avoiding anticoagulation. Larger randomized controlled trials are needed to identify subgroups in whom restarting anticoagulation might be beneficial or hazardous.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

Valery L. Feigin et al.

Summary: Regularly updated data on stroke including incidence, prevalence, mortality, disability, risk factors, and trends are crucial for evidence-based care planning. The Global Burden of Diseases Study provides comprehensive measurement of these metrics. From 1990 to 2019, while age-standardized rates improved, the number of strokes and deaths increased. Low-income countries had the highest stroke-related mortality and DALY rates, with high body-mass index being the fastest-growing risk factor.

LANCET NEUROLOGY (2021)

Review Pharmacology & Pharmacy

Efficacy and safety of restarting antiplatelet therapy for patients with spontaneous intracranial haemorrhage: A systematic review and meta-analysis

Bo Cheng et al.

Summary: Restarting antiplatelet therapy for patients with spontaneous intracranial haemorrhage is generally safe, but the benefits of reducing the risk of ischaemic vascular events and all-cause mortality were not significant. More randomized controlled trials are needed.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)

Article Clinical Neurology

Association Between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants From 4 Population-Based Cohort Studies

Santosh B. Murthy et al.

Summary: This study found that intracerebral hemorrhage was associated with an increased risk of ischemic stroke and myocardial infarction, suggesting it may be a novel risk marker for arterial ischemic events.

JAMA NEUROLOGY (2021)

Article Clinical Neurology

Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies

Linxin Li et al.

Summary: This study analyzed the risks of recurrent ICH, ischaemic stroke, and other serious vascular events in patients with spontaneous ICH, showing differences in risks based on ICH location and comorbid atrial fibrillation. These data enable risk stratification of patients in clinical practice and ongoing randomized trials.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage Extended Follow-up of the RESTART Randomized Clinical Trial

Rustam Al-Shahi Salman et al.

Summary: The RESTART trial aimed to investigate the effects of antiplatelet therapy on recurrent intracerebral hemorrhage and major vascular events in patients with prior antithrombotic therapy. The study found no statistically significant impact of antiplatelet therapy on these events in patients who had experienced intracerebral hemorrhage and previously received antithrombotic therapy.

JAMA NEUROLOGY (2021)

Review Medicine, General & Internal

Anticoagulants for acute ischaemic stroke

Xia Wang et al.

Summary: This study assessed the effectiveness and safety of early anticoagulation for people with acute ischaemic stroke. The results showed that early anticoagulant therapy reduced recurrent stroke risk but increased the risk of bleeding. Therefore, the routine use of anticoagulants for acute ischaemic stroke is not supported.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Article Clinical Neurology

Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020

Ashkan Shoamanesh et al.

Summary: Spontaneous intracerebral hemorrhage is a severe type of stroke with high mortality rate, and the latest update of the Canadian Stroke Best Practice Recommendations introduces a standalone module focusing on all aspects of care for intracerebral hemorrhage. It covers topics from initial clinical management to inpatient complications, addressing a comprehensive range of issues related to stroke management.

INTERNATIONAL JOURNAL OF STROKE (2021)

Review Clinical Neurology

PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients - PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis

Maurizio Paciaroni et al.

Summary: In patients with acute ICH, the use of anticoagulants to prevent VTE was found to be safe but the overall evidence level was low due to the low number of patients included in randomized clinical trials.

EUROPEAN NEUROLOGY (2021)

Article Public, Environmental & Occupational Health

Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults

Yiping Chen et al.

Lancet Global Health (2020)

Article Clinical Neurology

Longer term stroke risk in intracerebral haemorrhage survivors

Gargi Banerjee et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Cardiac & Cardiovascular Systems

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

Pavel Osmancik et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

Ken Okumura et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Medicine, General & Internal

Antithrombotic treatment after stroke due to intracerebral haemorrhage

Luke A. Perry et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Clinical Neurology

European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage

Thorsten Steiner et al.

INTERNATIONAL JOURNAL OF STROKE (2014)

Review Clinical Neurology

Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis

Michael Tin Chung Poon et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)

Article Medicine, Research & Experimental

The International Stroke Trial database

Peter A. G. Sandercock et al.

TRIALS (2011)

Review Medicine, General & Internal

Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Robert G. Hart et al.

ANNALS OF INTERNAL MEDICINE (2007)